Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 3541 AL 3555

Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders

Birajdar SV, Mazahir F, Alam MI, Kumar A, Yadav AK.

Eur J Pharmacol. 2023 Dec 15;961:176117. doi: 10.1016/j.ejphar.2023.176117. Epub 2023 Oct 30.

The Pathogenesis of Paroxysmal Kinesigenic Dyskinesia: Current Concepts

Li ZY, Tian WT, Huang XJ, Cao L.

Mov Disord. 2023 Apr;38(4):537-544. doi: 10.1002/mds.29326. Epub 2023 Jan 31.

Genetic Testing in Clinical Movement Disorders: A Case-Based Review

Kalia LV, Nimmo GAM, Mestre TA.

Semin Neurol. 2023 Feb;43(1):147-155. doi: 10.1055/s-0043-1763507. Epub 2023 Feb 28.

Purtscher-like retinopathy in patients with COVID-19

Kalavar M, El Khatib B, Suelves AM, Yanoga F.

Am J Ophthalmol Case Rep. 2023 Aug 23;32:101915. doi: 10.1016/j.ajoc.2023.101915. eCollection 2023 Dec.

Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases

Reed AL, Mitchell W, Alexandrescu AT, Alder NN.

Front Physiol. 2023 Nov 2;14:1263420. doi: 10.3389/fphys.2023.1263420. eCollection 2023.

Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases

Lizama BN, Kahle J, Catalano SM, Caggiano AO, Grundman M, Hamby ME.

Int J Mol Sci. 2023 Mar 26;24(7):6251. doi: 10.3390/ijms24076251.

Epigallocatechin Gallate: A Multifaceted Molecule for Neurological Disorders and Neurotropic Viral Infections

Rani A, Saini V, Patra P, Prashar T, Pandey RK, Mishra A, Jha HC.

ACS Chem Neurosci. 2023 Sep 6;14(17):2968-2980. doi: 10.1021/acschemneuro.3c00368. Epub 2023 Aug 17.

Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer's Disease

Shri SR, Manandhar S, Nayak Y, Pai KSR.

Adv Pharm Bull. 2023 Nov;13(4):688-700. doi: 10.34172/apb.2023.071. Epub 2023 Jan 23.

Mesenchymal Stem Cell Therapy for Huntington Disease: A Meta-Analysis

Liang XS, Sun ZW, Thomas AM, Li S.

Stem Cells Int. 2023 Apr 30;2023:1109967. doi: 10.1155/2023/1109967. eCollection 2023.

Case report: Cyclosporine A-induced extrapyramidal syndrome following hematopoietic stem cell transplantation

Al-Amrani F, Al Rawas A, Al-Ajmi E, Al Futaisi A.

Front Neurol. 2023 Apr 17;14:1140732. doi: 10.3389/fneur.2023.1140732. eCollection 2023.

The Regulation, Functions, and Signaling of miR-153 in Neurological Disorders, and Its Potential as a Biomarker and Therapeutic Target

Jaberi KR, Alamdari-Palangi V, Jaberi AR, Esmaeli Z, Shakeri A, Gheibi Hayat SM, Tajbakhsh A, Savardashtaki A.

Curr Mol Med. 2023;23(9):863-875. doi: 10.2174/1566524023666220817145638.

Understanding the mechanistic roles of environmental heavy metal stressors in regulating ferroptosis: adding new paradigms to the links with diseases

Sahoo K, Sharma A.

Apoptosis. 2023 Apr;28(3-4):277-292. doi: 10.1007/s10495-022-01806-0. Epub 2023 Jan 7.

The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation

Karvandi MS, Sheikhzadeh Hesari F, Aref AR, Mahdavi M.

Front Cell Neurosci. 2023 Mar 6;17:1105247. doi: 10.3389/fncel.2023.1105247. eCollection 2023.

Neurobiochemical characteristics of arginine-rich peptides explain their potential therapeutic efficacy in neurodegenerative diseases

Eskandari S, Rezayof A, Asghari SM, Hashemizadeh S.

Neuropeptides. 2023 Oct;101:102356. doi: 10.1016/j.npep.2023.102356. Epub 2023 Jun 23.

DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases

Kousparou C, Fyrilla M, Stephanou A, Patrikios I.

Int J Mol Sci. 2023 Jun 27;24(13):10717. doi: 10.3390/ijms241310717.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias